Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Roully Azhars"'
Autor:
Samsul Anwar, Mudatsir Mudatsir, Amanda Yufika, Jonny Karunia Fajar, Salwiyadi Salwiyadi, Muhammad N. Ferdian, Roully Azhars, Harapan Harapan, Aga S. Imanda, Arya U. Timur, Darul Ilham, Ricky Yordani, Juwita Sahputri, Yogambigai Rajamoorthy, Setia Pramana, Kurnia F. Jamil, Abram L. Wagner
Publikováno v:
F1000Research, Vol 8 (2023)
Background: Some Ebola vaccines have been developed and tested in phase III clinical trials. However, assessment of whether public have willingness to purchase or not, especially in unaffected areas, is lacking. The aim of this study was to determine
Externí odkaz:
https://doaj.org/article/b9d235eecf29441b8b961bbae1cd6291
Autor:
Mudatsir Mudatsir, Samsul Anwar, Jonny K. Fajar, Amanda Yufika, Muhammad N. Ferdian, Salwiyadi Salwiyadi, Aga S. Imanda, Roully Azhars, Darul Ilham, Arya U. Timur, Juwita Sahputri, Ricky Yordani, Setia Pramana, Yogambigai Rajamoorthy, Abram L. Wagner, Kurnia F. Jamil, Harapan Harapan
Publikováno v:
F1000Research, Vol 8 (2020)
Background: Some Ebola vaccines have been developed and tested in phase III clinical trials. However, assessment of whether public have willingness to purchase or not, especially in unaffected areas, is lacking. The aim of this study was to determine
Externí odkaz:
https://doaj.org/article/d784e845f3254ef6adf70718deb63a8d
Autor:
Arya Utama Timur, Maduka D. Ughasoro, Salwiyadi Salwiyadi, Muhammad Nazli Ferdian, Harapan Harapan, Reza Maulana, Samsul Anwar, Darul Ilham, Aga Sunanda Imanda, Roully Azhars, Dheni Fidiyah Fika, Juwita Sahputri, Hendra Kurniawan
Publikováno v:
Asian Pacific Journal of Tropical Disease, Vol 7, Iss 4, Pp 193-198 (2017)
Objective: To determine the acceptance towards a hypothetical Ebola virus vaccine (EVV) and associated factors in a non-affected country, Indonesia. Methods: A hospital-based, cross-sectional study was conducted in four regencies of Aceh, Indonesia.
Autor:
Roully Azhars, Mudatsir Mudatsir, Setia Pramana, Arya Utama Timur, Harapan Harapan, Aga Sunanda Imanda, Salwiyadi Salwiyadi, Amanda Yufika, Ricky Yordani, Muhammad Nazli Ferdian, Jonny Karunia Fajar, Abram L. Wagner, Juwita Sahputri, Yogambigai Rajamoorthy, Samsul Anwar, Kurnia Fitri Jamil, Darul Ilham
Publikováno v:
F1000Research
Background: Some Ebola vaccines have been developed and tested in phase III clinical trials. However, assessment of whether public have willingness to purchase or not, especially in unaffected areas, is lacking. The aim of this study was to determine